50 related articles for article (PubMed ID: 30673867)
21. Aberrations of MET are associated with copy number gain of EGFR and loss of PTEN and predict poor outcome in patients with salivary gland cancer.
Ach T; Zeitler K; Schwarz-Furlan S; Baader K; Agaimy A; Rohrmeier C; Zenk J; Gosau M; Reichert TE; Brockhoff G; Ettl T
Virchows Arch; 2013 Jan; 462(1):65-72. PubMed ID: 23242174
[TBL] [Abstract][Full Text] [Related]
22. The PI3K/AKT/mTOR signalling pathway is active in salivary gland cancer and implies different functions and prognoses depending on cell localisation.
Ettl T; Schwarz-Furlan S; Haubner F; Müller S; Zenk J; Gosau M; Reichert TE; Zeitler K
Oral Oncol; 2012 Sep; 48(9):822-30. PubMed ID: 22445095
[TBL] [Abstract][Full Text] [Related]
23. Loss of PTEN is associated with elevated EGFR and HER2 expression and worse prognosis in salivary gland cancer.
Ettl T; Baader K; Stiegler C; Müller M; Agaimy A; Zenk J; Kühnel T; Gosau M; Zeitler K; Schwarz S; Brockhoff G
Br J Cancer; 2012 Feb; 106(4):719-26. PubMed ID: 22240798
[TBL] [Abstract][Full Text] [Related]
24. EGFR, HER2, survivin, and loss of pSTAT3 characterize high-grade malignancy in salivary gland cancer with impact on prognosis.
Ettl T; Stiegler C; Zeitler K; Agaimy A; Zenk J; Reichert TE; Gosau M; Kühnel T; Brockhoff G; Schwarz S
Hum Pathol; 2012 Jun; 43(6):921-31. PubMed ID: 22154363
[TBL] [Abstract][Full Text] [Related]
25. Activation of the EGFR/ERK pathway in high-grade mucoepidermoid carcinomas of the salivary glands.
Lujan B; Hakim S; Moyano S; Nadal A; Caballero M; Diaz A; Valera A; Carrera M; Cardesa A; Alos L
Br J Cancer; 2010 Aug; 103(4):510-6. PubMed ID: 20664595
[TBL] [Abstract][Full Text] [Related]
26. Regulation of survivin by PI3K/Akt/p70S6K1 pathway.
Zhao P; Meng Q; Liu LZ; You YP; Liu N; Jiang BH
Biochem Biophys Res Commun; 2010 Apr; 395(2):219-24. PubMed ID: 20361940
[TBL] [Abstract][Full Text] [Related]
27. Study of FHIT and WWOX expression in mucoepidermoid carcinoma and adenoid cystic carcinoma of salivary gland.
Dincer N; Tezel GG; Sungur A; Himmetoglu C; Huebner K; Güler G
Oral Oncol; 2010 Mar; 46(3):195-9. PubMed ID: 20060354
[TBL] [Abstract][Full Text] [Related]
28. Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancer.
Laurent-Puig P; Cayre A; Manceau G; Buc E; Bachet JB; Lecomte T; Rougier P; Lievre A; Landi B; Boige V; Ducreux M; Ychou M; Bibeau F; Bouché O; Reid J; Stone S; Penault-Llorca F
J Clin Oncol; 2009 Dec; 27(35):5924-30. PubMed ID: 19884556
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas.
Ettl T; Schwarz S; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Histopathology; 2008 Nov; 53(5):567-77. PubMed ID: 18983466
[TBL] [Abstract][Full Text] [Related]
30. p27 and salivary cancer.
Ben-Izhak O; Akrish S; Gan S; Nagler RM
Cancer Immunol Immunother; 2009 Mar; 58(3):469-73. PubMed ID: 18663445
[TBL] [Abstract][Full Text] [Related]
31. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy.
Chu IM; Hengst L; Slingerland JM
Nat Rev Cancer; 2008 Apr; 8(4):253-67. PubMed ID: 18354415
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.
Woenckhaus M; Merk J; Stoehr R; Schaeper F; Gaumann A; Wiebe K; Hartmann A; Hofstaedter F; Dietmaier W
Hum Pathol; 2008 Jan; 39(1):126-36. PubMed ID: 17949785
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of FHIT inhibits apoptosis of colorectal cancer: mechanism and clinical implication.
Cao J; Li W; Xie J; Du H; Tang W; Wang H; Chen X; Xiao W; Li Y
Surg Oncol; 2006 Dec; 15(4):223-33. PubMed ID: 17382535
[TBL] [Abstract][Full Text] [Related]
34. Loss of p27 expression and microsatellite instability in sporadic colorectal cancer.
Sarli L; Bottarelli L; Azzoni C; Campanini N; Di Cola G; Barilli AL; Marchesi F; Mazzeo A; Salvemini C; Morari S; Di Mauro D; Donadei E; Necchi F; Roncoroni L; Bordi C
Surg Oncol; 2006 Aug; 15(2):97-106. PubMed ID: 17123889
[TBL] [Abstract][Full Text] [Related]
35. P27, SKP2, and extra-cellular signal-related kinase signalling in human salivary gland mucoepidermoid carcinoma.
Handra-Luca A; Ruhin B; Lesty C; Fouret P
Oral Oncol; 2006 Nov; 42(10):1005-10. PubMed ID: 16757206
[TBL] [Abstract][Full Text] [Related]
36. Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential.
Semba S; Trapasso F; Fabbri M; McCorkell KA; Volinia S; Druck T; Iliopoulos D; Pekarsky Y; Ishii H; Garrison PN; Barnes LD; Croce CM; Huebner K
Oncogene; 2006 May; 25(20):2860-72. PubMed ID: 16407838
[TBL] [Abstract][Full Text] [Related]
37. Expression and prognostic relevance of activated extracellular-regulated kinases (ERK1/2) in breast cancer.
Milde-Langosch K; Bamberger AM; Rieck G; Grund D; Hemminger G; Müller V; Löning T
Br J Cancer; 2005 Jun; 92(12):2206-15. PubMed ID: 15928662
[TBL] [Abstract][Full Text] [Related]
38. Nuclear or cytoplasmic expression of survivin: what is the significance?
Li F; Yang J; Ramnath N; Javle MM; Tan D
Int J Cancer; 2005 Apr; 114(4):509-12. PubMed ID: 15578717
[TBL] [Abstract][Full Text] [Related]
39. Extra-cellular signal-regulated ERK-1/ERK-2 pathway activation in human salivary gland mucoepidermoid carcinoma: association to aggressive tumor behavior and tumor cell proliferation.
Handra-Luca A; Bilal H; Bertrand JC; Fouret P
Am J Pathol; 2003 Sep; 163(3):957-67. PubMed ID: 12937136
[TBL] [Abstract][Full Text] [Related]
40. Tissue micro-array: a cost and time-effective method for correlative studies by regional and national cancer study groups.
Milanes-Yearsley M; Hammond ME; Pajak TF; Cooper JS; Chang C; Griffin T; Nelson D; Laramore G; Pilepich M
Mod Pathol; 2002 Dec; 15(12):1366-73. PubMed ID: 12481019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
